tradingkey.logo

Conmed Corp

CNMD

52.000USD

-0.290-0.55%
交易中 美东报价延迟15分钟
1.61B总市值
13.55市盈率 TTM

Conmed Corp

52.000

-0.290-0.55%
关于 Conmed Corp 公司
CONMED Corporation 是一家医疗技术公司,提供用于微创手术的手术设备和设备。其产品被外科医生和其他医疗保健专业人员用于各种专业领域,包括骨科、普通外科、妇科、胸外科和胃肠病学。其产品线包括骨科手术和普通外科手术。骨科手术包括运动医学和下肢器械和植入物、小骨、大骨和专用动力手术器械以及用于微创手术的成像系统,以及与运动医学同种异体移植组织的销售代表、推广和营销相关的费用。普通外科手术包括用于微创腹腔镜和胃肠道手术的内机械器械、烟雾排出装置、一系列心脏监测产品以及电外科发电机和相关器械。
公司简介
公司代码CNMD
公司名称Conmed Corp
上市日期Jul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
员工数量3900
证券类型Ordinary Share
年结日Jul 23
公司地址11311 Concept Boulevard
城市LARGO
上市交易所NYSE Consolidated
国家United States of America
邮编33773
电话17272142974
网址https://www.conmed.com/
公司代码CNMD
上市日期Jul 23, 1987
CEOMr. Patrick J. (Pat) Beyer
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
--
--
Mr. Mark B. Kaye
Mr. Mark B. Kaye
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
General Surgery
182.97M
56.95%
Orthopedic Surgery
138.29M
43.05%
地区USD
名称
营收
占比
United States
183.76M
57.20%
Europe & Middle East & Africa
63.68M
19.82%
Asia Pacific
43.71M
13.61%
Americas (excluding the United States)
30.11M
9.37%
业务
地区
业务USD
名称
营收
占比
General Surgery
182.97M
56.95%
Orthopedic Surgery
138.29M
43.05%
股东统计
更新时间: 5月14日 周三
更新时间: 5月14日 周三
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.74%
The Vanguard Group, Inc.
11.30%
EARNEST Partners, LLC
9.04%
Capital Research Global Investors
5.41%
State Street Global Advisors (US)
4.20%
Other
55.31%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.74%
The Vanguard Group, Inc.
11.30%
EARNEST Partners, LLC
9.04%
Capital Research Global Investors
5.41%
State Street Global Advisors (US)
4.20%
Other
55.31%
股东类型
持股股东
占比
Investment Advisor
64.48%
Investment Advisor/Hedge Fund
42.65%
Hedge Fund
3.72%
Research Firm
3.28%
Pension Fund
1.86%
Bank and Trust
0.79%
Individual Investor
0.58%
Family Office
0.05%
Sovereign Wealth Fund
0.05%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
649
36.35M
117.48%
-4.52M
2025Q1
664
36.95M
119.42%
-4.31M
2024Q4
649
36.65M
118.59%
-2.95M
2024Q3
644
35.57M
115.39%
-3.57M
2024Q2
660
37.07M
120.35%
-1.36M
2024Q1
657
36.04M
117.06%
-2.92M
2023Q4
642
36.87M
119.89%
-1.61M
2023Q3
624
36.40M
118.42%
-2.31M
2023Q2
606
36.19M
118.37%
-3.41M
2023Q1
592
37.15M
121.58%
-2.82M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.56M
14.74%
-49.31K
-1.07%
Mar 31, 2025
The Vanguard Group, Inc.
3.50M
11.31%
-68.84K
-1.93%
Mar 31, 2025
EARNEST Partners, LLC
2.80M
9.05%
-10.48K
-0.37%
Mar 31, 2025
Capital Research Global Investors
1.67M
5.41%
+96.23K
+6.10%
Mar 31, 2025
State Street Global Advisors (US)
1.30M
4.21%
-56.92K
-4.19%
Mar 31, 2025
Managed Account Advisors LLC
1.28M
4.14%
+139.05K
+12.19%
Mar 31, 2025
Westwood Management Corp. (Texas)
1.24M
4%
+360.34K
+41.07%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.17M
3.79%
+311.29K
+36.08%
Mar 31, 2025
Champlain Investment Partners, LLC
1.04M
3.37%
-258.19K
-19.85%
Mar 31, 2025
Silvercrest Asset Management Group LLC
1.04M
3.35%
+34.88K
+3.49%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
SPDR S&P Health Care Equipment ETF
1.67%
Invesco S&P SmallCap Health Care ETF
1.15%
ROBO Global Healthcare Technology & Innovation ETF
1.15%
Harbor Human Capital Factor US Small Cap ETF
1.06%
WisdomTree US SmallCap Quality Dividend Growth
0.31%
Royce Quant Small-Cap Quality Value ETF
0.28%
SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.25%
Franklin US Small Cap Multifactor Index ETF
0.24%
Principal U.S. Small-Cap ETF
0.23%
查看更多
SPDR S&P Health Care Equipment ETF
占比1.67%
Invesco S&P SmallCap Health Care ETF
占比1.15%
ROBO Global Healthcare Technology & Innovation ETF
占比1.15%
Harbor Human Capital Factor US Small Cap ETF
占比1.06%
WisdomTree US SmallCap Quality Dividend Growth
占比0.31%
Royce Quant Small-Cap Quality Value ETF
占比0.28%
SPDR S&P 600 Small Cap Value ETF
占比0.25%
iShares S&P Small-Cap 600 Value ETF
占比0.25%
Franklin US Small Cap Multifactor Index ETF
占比0.24%
Principal U.S. Small-Cap ETF
占比0.23%
分红派息
近5年累计派现 119.19M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
Feb 27, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 05, 2023
Mar 14, 2023
Dec 05, 2022
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2023 going ex on Dec 15, 2022
Dec 16, 2022
Jan 05, 2023
Dec 15, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI